NDC properties for "timolol 0.5 % (as timolol maleate 6.8 MG/ML) 24 HR Ophthalmic Solution" (RxCUI 1992299)
About this data
The tables show NDC propoerties for timolol 0.5 % (as timolol maleate 6.8 MG/ML) 24 HR Ophthalmic Solution with the RxCUI 1992299
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for timolol 0.5 % (as timolol maleate 6.8 MG/ML) 24 HR Ophthalmic Solution (RxCUI 1992299)
ANDA | ANDA204936 |
---|---|
ANDA | ANDA216653 |
MMSL_CODE | BD12430 |
MMSL_CODE | CD12430 |
MMSL_CODE | MTH_RXN_BD3330 |
RxCUI | 1992299 |
SPL_SET_ID | 3c20b537-88c6-4ec7-a359-e0ba67afe431 |
SPL_SET_ID | b686bbad-1ef7-4b94-a316-4d182a40b89a |
SPL_SET_ID | bfd95433-e47a-4c5c-9bdf-77bffc13544d |
SPL_SET_ID | df10af59-3b72-ca33-fd89-d9fcd0d61e9b |
VUID | 4037944 |
Prescribable Synonym | timolol 0.5 % 24HR Ophthalmic Solution |
RXNAV_STR | 24 HR timolol 5 MG/ML Ophthalmic Solution |
RxNorm Name | 24 HR timolol 5 MG/ML Ophthalmic Solution |
RxNorm Synonym | timolol 0.5 % (as timolol maleate 6.8 MG/ML) 24 HR Ophthalmic Solution |
RxNorm Synonym | timolol 0.5 % 24 HR Ophthalmic Solution |
Related queries | Interactions (for RxCUI 1992299) |
NDC Properties
NDC Item 60505100501
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-1 |
NDC Item | 60505100501 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-1) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 60505100504
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-4 |
NDC Item | 60505100504 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-4) / 2.5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 68682004525
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-25 |
NDC Item | 68682004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 68682004550
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-50 |
NDC Item | 68682004550 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-50) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 70069051601
NDC 9 | 70069-516 |
---|---|
NDC 10 | 70069-516-01 |
NDC Item | 70069051601 |
Packaging | 1 BOTTLE in 1 CARTON (70069-516-01) / 2.5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-516 |
NDC Item 70069051701
NDC 9 | 70069-517 |
---|---|
NDC 10 | 70069-517-01 |
NDC Item | 70069051701 |
Packaging | 1 BOTTLE in 1 CARTON (70069-517-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-517 |
NDC Item 82260004505
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-05 |
NDC Item | 82260004505 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 82260004525
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-25 |
NDC Item | 82260004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 60505100501
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-1 |
NDC Item | 60505100501 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-1) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 60505100504
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-4 |
NDC Item | 60505100504 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-4) / 2.5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 68682004525
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-25 |
NDC Item | 68682004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 68682004550
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-50 |
NDC Item | 68682004550 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-50) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 70069051601
NDC 9 | 70069-516 |
---|---|
NDC 10 | 70069-516-01 |
NDC Item | 70069051601 |
Packaging | 1 BOTTLE in 1 CARTON (70069-516-01) / 2.5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-516 |
NDC Item 70069051701
NDC 9 | 70069-517 |
---|---|
NDC 10 | 70069-517-01 |
NDC Item | 70069051701 |
Packaging | 1 BOTTLE in 1 CARTON (70069-517-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-517 |
NDC Item 82260004505
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-05 |
NDC Item | 82260004505 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 82260004525
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-25 |
NDC Item | 82260004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 60505100501
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-1 |
NDC Item | 60505100501 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-1) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 60505100504
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-4 |
NDC Item | 60505100504 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-4) / 2.5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 68682004525
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-25 |
NDC Item | 68682004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 68682004550
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-50 |
NDC Item | 68682004550 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-50) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 70069051601
NDC 9 | 70069-516 |
---|---|
NDC 10 | 70069-516-01 |
NDC Item | 70069051601 |
Packaging | 1 BOTTLE in 1 CARTON (70069-516-01) / 2.5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-516 |
NDC Item 70069051701
NDC 9 | 70069-517 |
---|---|
NDC 10 | 70069-517-01 |
NDC Item | 70069051701 |
Packaging | 1 BOTTLE in 1 CARTON (70069-517-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-517 |
NDC Item 82260004505
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-05 |
NDC Item | 82260004505 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 82260004525
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-25 |
NDC Item | 82260004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 60505100501
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-1 |
NDC Item | 60505100501 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-1) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 60505100504
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-4 |
NDC Item | 60505100504 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-4) / 2.5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 68682004525
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-25 |
NDC Item | 68682004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 68682004550
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-50 |
NDC Item | 68682004550 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-50) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 70069051601
NDC 9 | 70069-516 |
---|---|
NDC 10 | 70069-516-01 |
NDC Item | 70069051601 |
Packaging | 1 BOTTLE in 1 CARTON (70069-516-01) / 2.5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-516 |
NDC Item 70069051701
NDC 9 | 70069-517 |
---|---|
NDC 10 | 70069-517-01 |
NDC Item | 70069051701 |
Packaging | 1 BOTTLE in 1 CARTON (70069-517-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-517 |
NDC Item 82260004505
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-05 |
NDC Item | 82260004505 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 82260004525
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-25 |
NDC Item | 82260004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 60505100501
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-1 |
NDC Item | 60505100501 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-1) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 60505100504
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-4 |
NDC Item | 60505100504 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-4) / 2.5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 68682004525
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-25 |
NDC Item | 68682004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 68682004550
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-50 |
NDC Item | 68682004550 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-50) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 70069051601
NDC 9 | 70069-516 |
---|---|
NDC 10 | 70069-516-01 |
NDC Item | 70069051601 |
Packaging | 1 BOTTLE in 1 CARTON (70069-516-01) / 2.5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-516 |
NDC Item 70069051701
NDC 9 | 70069-517 |
---|---|
NDC 10 | 70069-517-01 |
NDC Item | 70069051701 |
Packaging | 1 BOTTLE in 1 CARTON (70069-517-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-517 |
NDC Item 82260004505
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-05 |
NDC Item | 82260004505 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 82260004525
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-25 |
NDC Item | 82260004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 60505100501
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-1 |
NDC Item | 60505100501 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-1) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 60505100504
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-4 |
NDC Item | 60505100504 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-4) / 2.5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 68682004525
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-25 |
NDC Item | 68682004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 68682004550
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-50 |
NDC Item | 68682004550 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-50) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 70069051601
NDC 9 | 70069-516 |
---|---|
NDC 10 | 70069-516-01 |
NDC Item | 70069051601 |
Packaging | 1 BOTTLE in 1 CARTON (70069-516-01) / 2.5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-516 |
NDC Item 70069051701
NDC 9 | 70069-517 |
---|---|
NDC 10 | 70069-517-01 |
NDC Item | 70069051701 |
Packaging | 1 BOTTLE in 1 CARTON (70069-517-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-517 |
NDC Item 82260004505
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-05 |
NDC Item | 82260004505 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 82260004525
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-25 |
NDC Item | 82260004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 60505100501
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-1 |
NDC Item | 60505100501 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-1) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 60505100504
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-4 |
NDC Item | 60505100504 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-4) / 2.5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 68682004525
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-25 |
NDC Item | 68682004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 68682004550
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-50 |
NDC Item | 68682004550 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-50) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 70069051601
NDC 9 | 70069-516 |
---|---|
NDC 10 | 70069-516-01 |
NDC Item | 70069051601 |
Packaging | 1 BOTTLE in 1 CARTON (70069-516-01) / 2.5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-516 |
NDC Item 70069051701
NDC 9 | 70069-517 |
---|---|
NDC 10 | 70069-517-01 |
NDC Item | 70069051701 |
Packaging | 1 BOTTLE in 1 CARTON (70069-517-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-517 |
NDC Item 82260004505
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-05 |
NDC Item | 82260004505 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 82260004525
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-25 |
NDC Item | 82260004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 60505100501
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-1 |
NDC Item | 60505100501 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-1) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 60505100504
NDC 9 | 60505-1005 |
---|---|
NDC 10 | 60505-1005-4 |
NDC Item | 60505100504 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-4) / 2.5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA204936 |
FDA SPL set id | 788504 |
Labeler | Apotex Corp |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2017-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 60505-1005 |
NDC Item 68682004525
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-25 |
NDC Item | 68682004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 68682004550
NDC 9 | 68682-045 |
---|---|
NDC 10 | 68682-045-50 |
NDC Item | 68682004550 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-50) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 448355 |
Labeler | Oceanside Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-05-30 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 68682-045 |
NDC Item 70069051601
NDC 9 | 70069-516 |
---|---|
NDC 10 | 70069-516-01 |
NDC Item | 70069051601 |
Packaging | 1 BOTTLE in 1 CARTON (70069-516-01) / 2.5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-516 |
NDC Item 70069051701
NDC 9 | 70069-517 |
---|---|
NDC 10 | 70069-517-01 |
NDC Item | 70069051701 |
Packaging | 1 BOTTLE in 1 CARTON (70069-517-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA216653 |
FDA SPL set id | 796359 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-09 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70069-517 |
NDC Item 82260004505
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-05 |
NDC Item | 82260004505 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |
NDC Item 82260004525
NDC 9 | 82260-045 |
---|---|
NDC 10 | 82260-045-25 |
NDC Item | 82260004525 |
Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 826867 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2022-06-23 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA021516 |
Related queries | Properties for NDC 9 82260-045 |